Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pierre Gravier Insider Profile
4 Followers
Pierre Gravier, CFO at PTC Therapeutics, holds 53.53K shares in PTC Therapeutics (Ticker: PTCT), holds ― shares in Cassava Sciences (Ticker: SAVA). Most recently, Pierre Gravier Sold ― shares of PTC Therapeutics on Jul 18, 2024 for an estimated value of 77.19K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-8.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Pierre Gravier holds in companies
Most Profitable Insider Trade
The most profitable trade made by Pierre Gravier
Pierre Gravier's Trading History
PTC Therapeutics
Jul 18, 2024
CFO
Informative Sell
77.19K
$2.11M
Cassava Sciences
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Pierre Gravier's performance on stock
You May Also Like
Pierre Gravier insider profile FAQ
What is the percentage of profitable transactions made by Pierre Gravier?
The percentage of profitable transactions made by Pierre Gravier is 50%.
What is the average return per transaction made by Pierre Gravier?
The average return per transaction made by Pierre Gravier is -8.00%.
What stocks does Pierre Gravier hold?
Pierre Gravier holds: PTCT, SAVA stocks.
What was Pierre Gravier’s latest transaction?
Pierre Gravier latest transaction was an Informative Sell of $77.19K.
What was Pierre Gravier's most profitable transaction?
Pierre Gravier’s most profitable transaction was an Informative Buy of PTCT stock on December 14, 2023. The return on the trade was 18.80%.
What is Pierre Gravier's role in PTC Therapeutics?
Pierre Gravier's role in PTC Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.